跳转至内容
Merck

T9549

Sigma-Aldrich

凝血酶 来源于牛血浆

powder, suitable for cell culture, ≥1,500 NIH units/mg protein (E1%/280 = 19.5)

别名:

IIa 因子

登录查看公司和协议定价


About This Item

CAS号:
EC 号:
MDL编号:
UNSPSC代码:
12352204

表单

powder

比活

≥1,500 NIH units/mg protein (E1%/280 = 19.5)

分子量

heavy chain ~31 kDa
light chain ~6 kDa

技术

cell culture | mammalian: suitable

UniProt登记号

运输

dry ice

储存温度

−20°C

基因信息

cow ... F2(280685)

正在寻找类似产品? 访问 产品对比指南

一般描述

凝血酶是止血过程中的最终凝血蛋白酶,可同时促进促凝血和抗凝血作用。

应用

凝血酶用于位点融合蛋白的位点特异性裂解,重组融合蛋白含有可进入的凝血酶识别位点,用于去除亲和标签。在一项研究中,凝血酶被用于评估用于生物物理学和结构表征的腺苷受体肽生物合成的表达和纯化系统。 [1]

生化/生理作用

丝氨酸蛋白酶,选择性断开纤维蛋白原中的精氨酸-甘氨酸键,形成纤维蛋白以及纤维蛋白肽 A 和 B。

单位定义

活性以NIH单位表示,通过与NIH凝血酶参考标准品直接对比来测定。

重悬

当使用 1mL 水复原时,小瓶将在 0.15M 氯化钠和 0.05M 柠檬酸钠中以及 pH 6.5 下达到规定的活性。

分析说明

基于 Biggs 改性法的 NIH 分析过程使用 0.2mL 稀释血浆(由血浆与等量生理盐水混合制得)作为底物,以及 0.1mL 凝血酶样品(在含 1% 白蛋白缓冲液中保持稳定)。只使用 15-25 秒之间的凝血时间分析凝血酶浓度。
活性是通过与一种K批次的NIH凝血酶参考标准品进行直接比较而得到并以NIH单位进行表达的。

其他说明

象形图

Health hazardExclamation mark

警示用语:

Danger

危险分类

Eye Irrit. 2 - Resp. Sens. 1 - Skin Irrit. 2 - STOT SE 3

靶器官

Respiratory system

储存分类代码

11 - Combustible Solids

WGK

WGK 2

闪点(°F)

Not applicable

闪点(°C)

Not applicable


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Andrew F Uehlin et al.
Pharmaceutics, 14(2) (2022-02-27)
In this study, we report a biohybrid oriented fibrous scaffold based on nanofibers of poly(l-lactic acid) (PLLA)/fibrin produced by electrospinning and subsequent post-treatment. Induced hydrolytic degradation of the fibers in 0.25 M NaOH solution for various time periods followed by
Zachary T Britton et al.
Protein expression and purification, 84(2), 224-235 (2012-06-23)
Biophysical and structural characterization of G protein-coupled receptors (GPCRs) has been limited due to difficulties in expression, purification, and vitro stability of the full-length receptors. "Divide and conquer" approaches aimed at the NMR characterization of peptides corresponding to specific regions
Sharon Wei Ling Lee et al.
Advanced healthcare materials, 9(7), e1901486-e1901486 (2020-03-04)
Polymer nanoparticles (NPs), due to their small size and surface functionalization potential have demonstrated effective drug transport across the blood-brain-barrier (BBB). Currently, the lack of in vitro BBB models that closely recapitulate complex human brain microenvironments contributes to high failure
Yuya Nakatani et al.
Archives of oral biology, 73, 172-178 (2016-10-25)
Platelet-rich plasma (PRP) is typically isolated and applied immediately after preparation, making it both a time- and labor-intensive addition to the operative procedure. Thus, it would be convenient if PRP could be preserved. We evaluated the efficacy of freeze-dried PRP
Jawed Fareed et al.
Annual review of pharmacology and toxicology, 52, 79-99 (2011-08-09)
Since the discovery of heparin nearly a century ago, there have been large gaps in the development of anticoagulants. The discovery of warfarin was the first step toward using oral anticoagulants, but warfarin use has been associated with its own

Questions

Reviews

No rating value

Active Filters

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门